The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

CHENNAI: In a milestone move, the US Food and Drug Administration has given the green light to the world's first blood test ...

The U.S. Food and Drug Administration (FDA) has cleared the first blood test to aid in diagnosis of Alzheimer's disease. The test detects amyloid plaques, a hallmark of Alzheimer's disease, through a ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.

The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood ...

The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer's disease. It is approved for use in ...

Alzheimer’s disease, which is one of the most common forms of dementia, affects millions worldwide, and early detection has ...

The Ford Escape is one of those good little SUVs that has nearly always done most things right, but there's often something ...

The newly approved test, developed by Fujirebio Diagnostics, Inc., is designed for patients aged 55 and older who are ...

Summer jobs can be beneficial for students in their first years of high school who have not yet met the minimum age ...